- 首页
- 公司介绍
- 热门促销
-
全部产品
-
试剂盒
- |
-
一抗
- |
-
二抗
- |
-
蛋白
- |
-
免疫组化试剂
- |
-
WB 试剂
- PonceauS Staining Solution
- PBST Washing Buffer, 10X
- 1.5M Tris-HCl Buffer, pH8.8
- 1M Tris-HCl Buffer, pH6.8
- 10% SDS Solution
- Prestained Protein Marker
- TBST Washing Buffer, 10X
- SDS PAGE Loading Buffer, 5X
- Stripping Buffered Solution
- Tris Buffer, pH7.4, 10X
- Total Protein Extraction Kit
- Running Buffer, 10X
- Transfer Buffer, 10X
- 30% Acr-Bis(29:1) Solution
- Tris电泳液速溶颗粒
- PBS(1X, premixed powder)
- TBS(1X, premixed powder)
- 快速封闭液
- 转膜液速溶颗粒
- Chemical reagents
- 公司新闻
- 营销网络
- 资源中心
- 联系我们
KG19 Polyclonal Antibody
- 货号:YT2466
- 应用:WB;IHC;IF;ELISA
- 种属:Human;Mouse
- 蛋白名称:
- BRI3-binding protein
- 免疫原:
- The antiserum was produced against synthesized peptide derived from human BRI3B. AA range:1-50
- 特异性:
- KG19 Polyclonal Antibody detects endogenous levels of KG19 protein.
- 组成:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 来源:
- Polyclonal, Rabbit,IgG
- 稀释:
- WB 1:500 - 1:2000. IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.
- 纯化工艺:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 储存:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- 其他名称:
- BRI3BP;KG19;BRI3-binding protein;I3-binding protein;Cervical cancer 1 proto-oncogene-binding protein KG19;HCCRBP-1
- 背景:
- tissue specificity:Most abundantly expressed in brain, liver and kidney.,
- 功能:
- tissue specificity:Most abundantly expressed in brain, liver and kidney.,
- 细胞定位:
- Mitochondrion outer membrane ; Multi-pass membrane protein .
- 组织表达:
- Most abundantly expressed in brain, liver and kidney (PubMed:11860200). Overexpressed in leukemia and lymphoma cell lines, as well as in various carcinomas (PubMed:17943721).
- Immunohistochemistry analysis of paraffin-embedded human brain tissue, using BRI3B Antibody. The picture on the right is blocked with the synthesized peptide.
- Western blot analysis of lysates from RAW264.7 cells, using BRI3B Antibody. The lane on the right is blocked with the synthesized peptide.